This HTML document is not a form. Its purpose is to display the information as found on the form for viewing purposes only. If you wish to use the form, you must use the alternate format below.
Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.
Participation in the Forum is only open to International Regulatory Agencies. There is no registration fee, however participants are responsible for their own travel and accommodation costs.
Requests for Registration must be submitted by 17:00 (Eastern Standard Time) Friday, August 17, 2012 and should be sent by Email or Fax to:
HPFB Forum Registrar
Email: HPFB_Forum_DGPSA@hc-sc.gc.ca
Fax: 011-613-941-3694
Once we receive your completed 'Request for Registration' form, an official Invitation Letter will be sent to you within 1-2 weeks. If you have not received a letter within 2 weeks of submitting your Request for Registration, please contact us at the above Email or by Telephone (011-613-941-9290) to ensure we have received your information. Details on venue and special guest room rates will follow.
Please indicate if you have special requirements during the Forum (e.g. wheelchair accessibility):
Simultaneous interpretation will be offered in English and French for all sessions. Spanish interpretation will only be offered for specific product lines (to be confirmed but tentatively anticipated to include Medical Devices and the Vaccines Lot Release Course). All materials will be available in English and French.
| Languages in which you have sufficient working ability to participate in the Forum. (Please select ALL that apply) |
Preferred Language (Please select only ONE) |
|
|---|---|---|
| English | ||
| French | ||
| Spanish |
This year, only electronic versions of Forum materials will be provided. All participants will receive a USB Memory Stick on Day 1 of the program. We request that all participants bring their own laptops (and international adaptor). Please contact us if you have any questions or concerns.
The 2012 Forum will provide a detailed overview of the Canadian regulatory process for biologics, vaccines, pharmaceuticals, medical devices and natural health products, throughout the pre- and post-market product lifecycle. To allow for a comprehensive examination of regulatory issues, some sessions will be offered in parallel.
Please indicate the product line of greatest interest to you. This does not restrict your attendance at the other sessions.
Product Line of Primary Interest (Select ONE)
Please indicate the topics of greatest interest to you.
Pre-Market Topics of Interest (Select ALL that apply)
Please indicate the topics of greatest interest to you. Select ALL that apply.
Post-Market Surveillance
Establishment Licensing
Compliance verification, Border, Laboratory
Inspections
Please also let us know if there are any other regulatory topics of specific interest to you.
While we will not be able to include all possible regulatory topics in the Program, we will do our best to accommodate your suggestions: